Skip to content

Kunkel Lori Anne Insider Trading -- Recent SEC Form 4 Transactions

Kunkel Lori Anne (CIK 1536368) reported 10 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-11-03). Recent activity: Buy ELVN (3,741 shares), Buy ELVN (7,300 shares), Sell ELVN (4,111 shares), Sell ELVN (5,889 shares), Sell ELVN (7,779 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-11-03Enliven Therapeutics, Inc. (ELVN)DirectorBuy3,741$4,190
2026-11-03Enliven Therapeutics, Inc. (ELVN)DirectorBuy7,300$133,590
2026-07-08Enliven Therapeutics, Inc. (ELVN)DirectorSell4,111$205,468
2026-07-08Enliven Therapeutics, Inc. (ELVN)DirectorSell5,889$299,397
2026-06-09Enliven Therapeutics, Inc. (ELVN)DirectorSell7,779$266,664
2026-06-09Enliven Therapeutics, Inc. (ELVN)DirectorSell1,867$66,017
2026-06-09Enliven Therapeutics, Inc. (ELVN)DirectorSell354$12,680
2025-12-19Enliven Therapeutics, Inc. (ELVN)DirectorBuy15,958$17,873
2025-12-09Oric Pharmaceuticals, Inc. (ORIC)DirectorBuy10,000$79,000
2025-12-05Oric Pharmaceuticals, Inc. (ORIC)DirectorBuy5,534$20,752

Source: SEC Form 4 filings · as of 2026-11-03